A detailed history of China Universal Asset Management Co., Ltd. transactions in Catalent, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,301 shares of CTLT stock, worth $399,987. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,301
Previous 6,301 -0.0%
Holding current value
$399,987
Previous $354,000 7.63%
% of portfolio
0.04%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$32.18 - $46.57 $1.23 Million - $1.78 Million
-38,319 Reduced 85.88%
6,301 $283,000
Q3 2023

May 21, 2024

BUY
$44.2 - $50.2 $600,899 - $682,469
13,595 Added 43.82%
44,620 $2.03 Million
Q3 2023

Oct 30, 2023

BUY
$44.2 - $50.2 $600,899 - $682,469
13,595 Added 43.82%
44,620 $2.03 Million
Q2 2023

May 21, 2024

SELL
$31.86 - $67.26 $474,618 - $1 Million
-14,897 Reduced 32.44%
31,025 $1.35 Million
Q2 2023

Jul 27, 2023

SELL
$31.86 - $67.26 $474,618 - $1 Million
-14,897 Reduced 32.44%
31,025 $1.35 Million
Q1 2023

May 21, 2024

SELL
$45.44 - $74.26 $445,357 - $727,822
-9,801 Reduced 17.59%
45,922 $3.02 Million
Q1 2023

Apr 27, 2023

SELL
$45.44 - $74.26 $445,357 - $727,822
-9,801 Reduced 17.59%
45,922 $3.02 Million
Q4 2022

May 21, 2024

BUY
$41.39 - $81.0 $2.05 Million - $4 Million
49,422 Added 784.35%
55,723 $2.51 Million
Q4 2022

Jan 31, 2023

BUY
$41.39 - $81.0 $1.73 Million - $3.38 Million
41,690 Added 297.09%
55,723 $2.51 Million
Q3 2022

Oct 21, 2022

SELL
$72.36 - $113.1 $2.87 Million - $4.49 Million
-39,717 Reduced 73.89%
14,033 $1.02 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $1.07 Million - $1.4 Million
12,251 Added 29.52%
53,750 $5.77 Million
Q1 2022

Apr 25, 2022

SELL
$94.19 - $124.49 $3.06 Million - $4.04 Million
-32,470 Reduced 43.9%
41,499 $4.6 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $8.84 Million - $10.3 Million
73,969 New
73,969 $9.47 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.